Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.jvca.2017.03.024 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A 52-Year-Old Woman With Shortness of Breath and Left Lower Back Pain.
Chest
March 2025
Department of Pulmonary and Critical Care Medicine, The University of Toledo, Toledo, OH.
A 52-year-old woman presented to the clinic with progressively worsening shortness of breath associated with intermittent pleuritic left lower back pain for the past 6 months. The patient denied any cough, hemoptysis, fever, chills, or weight loss. She had a history of smoking cigarettes for more than 10 years but quit almost 20 years ago.
View Article and Find Full Text PDFAirway-centered invasive pulmonary aspergillosis featuring histopathologic fruiting bodies in an immunocompetent patient with a rare incidental finding of thyroid gland Schwannoma: a case report.
BMC Infect Dis
March 2025
Department of Infectious diseases, University of Louisville Hospital, Louisville, USA.
Introduction: Invasive pulmonary aspergillosis (IPA) is typically associated with immunocompromised patients, but rare occurrences have been documented in immunocompetent individuals. This presents diagnostic and therapeutic challenges due to atypical presentations and less apparent risk factors.
Case Presentation: A 67-year-old Cambodian American female with a history of stable pulmonary nodules and a left neck schwannoma presented with a two-week history of cough and hemoptysis.
Clinical outcomes, toxic effect, and immune microenvironment changes of drug-eluting bead bronchial arterial chemoembolisation/bronchial arterial chemoembolization combined with immunotherapy in treating elderly patients with non-small cell lung cancer.
Clin Radiol
February 2025
Department of Oncology Center, Lishui Municipal Central Hospital, Lishui, Zhejiang 323000, China; The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui, Zhejiang 323000, China. Electronic address:
Aim: Systemic chemotherapy plus immune checkpoint inhibitors (ICIs) are first-line treatment for advanced non-small cell lung cancer (NSCLC). However, elderly patients typically have comorbidities that tend to limit the use of chemotherapy at standard dosage and frequency. Drug-eluting bead bronchial arterial chemoembolisation (DEB-BACE)/bronchial arterial chemoembolization (BACE) represents options in such patients.
View Article and Find Full Text PDFAnalysis of risk factors for recurrence within 6 months after bronchial artery embolization for massive hemoptysis due to pulmonary tuberculosis.
Medicine (Baltimore)
March 2025
Department of Radiology, Jiangsu Province Changzhou 3rd Hospital, Jiangsu, Changzhou, China.
This study aims to investigate the causes and risk factors of recurrence within 6 months after transcatheter bronchial artery embolization for massive hemoptysis in pulmonary tuberculosis. A retrospective observational study was conducted on the clinical data of 237 patients with pulmonary tuberculosis and massive hemoptysis who relapsed within 6 months after bronchial artery embolization. Univariate analysis was first conducted to screen for risk factors with statistical significance, and then multivariate logistic regression analysis was performed to infer the risk factors that might lead to the recurrence of hemoptysis.
View Article and Find Full Text PDFPredictors of 12-Month Recurrence of Hemoptysis after Bronchial Artery Embolization.
Arch Iran Med
February 2025
Department of Radiology, Mashhad University of Medical Sciences, Mashhad, Iran.
Background: Despite the high success rate of bronchial artery embolization (BAE), hemoptysis probably recurs. This study investigated risk factors of 12-month hemoptysis recurrence after BAE in an Iranian population.
Methods: In this prospective cohort, we followed up 101 patients for 12 months after BAE.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!